UBS Group AG - LANDOS BIOPHARMA INC ownership

LANDOS BIOPHARMA INC's ticker is LABP and the CUSIP is 515069102. A total of 36 filers reported holding LANDOS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LANDOS BIOPHARMA INC
ValueSharesWeighting
Q1 2023$1,871
+895.2%
6,279
+1574.4%
0.00%
Q4 2022$188
-81.2%
375
-69.8%
0.00%
Q2 2022$1,000
-94.4%
1,243
-67.3%
0.00%
Q4 2021$18,0000.0%3,805
+108.2%
0.00%
Q1 2021$18,0001,8280.00%
Other shareholders
LANDOS BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 1,827,478$2,696,0002.05%
Perceptive Advisors 14,869,915$21,933,0000.44%
RTW INVESTMENTS, LP 4,275,722$6,307,0000.13%
ArchPoint Investors 128,750$190,0000.07%
Orbimed Advisors 283,217$418,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 159,000$235,0000.01%
Walleye Capital LLC 93,533$138,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 158,875$234,0000.00%
Renaissance Technologies 340,500$502,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,324$3,0000.00%
View complete list of LANDOS BIOPHARMA INC shareholders